STUDY SEARCH RESULTS

1 study found for your search request:  7684A-006

Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination with Concurrent Chemoradiotherapy Foll...
Condition: Carcinoma, Non-Small-Cell Lung
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT05298423
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2024 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  U.S. Corporate Site